Hims & Hers Health, Inc. reported that institutional investor Capital World Investors beneficially owns 14,322,912 shares of its common stock, representing 6.5% of the class, based on 219,270,891 shares believed to be outstanding as of the ownership date.
Hims & Hers Health, Inc. reported that institutional investor Capital World Investors beneficially owns 14,322,912 shares of its common stock, representing 6.5% of the class, based on 219,270,891 shares believed to be outstanding as of the ownership date.
Capital World Investors reports sole voting power over 14,316,043 shares and sole dispositive power over 14,322,912 shares, with no shared voting or dispositive power. The shares are stated to be acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Positive
None.
Negative
None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of HIMS common stock does Capital World Investors own?
Capital World Investors reports beneficial ownership of 6.5% of Hims & Hers Health, Inc. common stock. This corresponds to 14,322,912 shares, based on 219,270,891 shares of common stock believed to be outstanding at the measurement date.
How many HIMS shares does Capital World Investors control voting power over?
Capital World Investors has sole voting power over 14,316,043 shares of Hims & Hers Health, Inc. It reports no shared voting power, indicating all voting authority for the reported position is held on a sole, rather than joint, basis.
Does Capital World Investors share dispositive power over HIMS shares?
Capital World Investors reports sole dispositive power over 14,322,912 shares of Hims & Hers Health, Inc. common stock and no shared dispositive power. Sole dispositive power means it alone decides if and when these shares are sold or otherwise transferred.
Is Capital World Investors seeking to influence control of Hims & Hers (HIMS)?
The filing states the securities were acquired and are held in the ordinary course of business. It further certifies they were not acquired and are not held for the purpose or effect of changing or influencing the control of Hims & Hers Health, Inc.
Who signed the HIMS beneficial ownership filing for Capital World Investors?
The statement was signed by Timothy J. Moon, identified as Vice President and Senior Counsel of Capital Research and Management Company. He certifies, after reasonable inquiry, that the information provided about the Hims & Hers position is true, complete, and correct.
What relationship does Capital World Investors have with other Capital Group entities in this filing?
The filing explains that Capital World Investors is a division of Capital Research and Management Company and related investment management entities. These entities collectively provide investment management services under the Capital World Investors name and are deemed beneficial owners of the reported HIMS shares.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Hims & Hers Health, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
433000106
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
433000106
1
Names of Reporting Persons
Capital World Investors
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
14,316,043.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
14,322,912.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
14,322,912.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.5 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Hims & Hers Health, Inc.
(b)
Address of issuer's principal executive offices:
2269 Chestnut Street, #523, San Francisco, CA 94123
Item 2.
(a)
Name of person filing:
Capital World Investors
(b)
Address or principal business office or, if none, residence:
333 SOUTH HOPE STREET, 55TH FLOOR, LOS ANGELES, CALIFORNIA 90071
(c)
Citizenship:
N/A
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
433000106
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
14,322,912 **
**Capital World Investors ("CWI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CWI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital World Investors." CWI is deemed to be the beneficial owner of 14,322,912 shares or 6.5% of the 219,270,891 shares believed to be outstanding.
(b)
Percent of class:
6.5 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
14,316,043
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
14,322,912
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Capital World Investors
Signature:
Timothy J. Moon
Name/Title:
Vice President and Senior Counsel, Capital Research and Management Company
